type here...

CATEGORIES

Breaking Research

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

NAMI Poll: Parents Want Mental Health Education in Schools, Mental Health Days Off for Students

Medika Life -
ARLINGTON, Va., Dec. 15, 2021 /PRNewswire/ -- An overwhelming number of parents support mental health education in schools and "mental health days" for their children, according...

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

HPV Urban Legends – From Contagion to Symptoms to Risks to Prevention – There Are More Rare Concerns that Deserve Our Attention

Gil Bashe, Medika Life Editor -
Inaugural International Recurrent Respiratory Papillomatosis Awareness Day

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories